Skip to main content
Log in

Pharmacokinetics of prednisolone in children with the nephrotic syndrome

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The aim of this study was to establish whether the criteria for the clinical effectiveness of steroids are correlated with the pharmacokinetics of prednisolone in children treated with prednisone during an attack of idiopathic nephrotic syndrome (INS). Thirteen patients with nephrosis were included. Prednisolone, prednisone and cortisol levels were measured using a specific high-performance liquid chromatography assay after an oral dose of 1 mg/kg body weight of prednisone taken at the onset of the disease. All the pharmacokinetic parameters, including the conversion of prednisone to prednisolone were similar to the data already published in children with INS. No correlation was found between the values of pharmacokinetic parameters and criteria of clinical effectiveness. Hypo-albuminaemia was significantly correlated with the area under the plasma-concentration curve but not with the elimination half-life of prednisolone. Moreover, the prednisolone elimination half-life correlated with the urinary exretion of 17-hydroxycorticosteroids achieved in the first 6h. The present study suggests that routine measurements of prednisolone kinetics do not help when assessing the treatment of children with INS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bergrem H (1983) Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis. Kidney Int 23: 876–881

    PubMed  Google Scholar 

  2. Frey FJ, Frey BM (1982) Altered prednisolone kinetics in patients with the nephrotic syndrome. Nephron 32: 45–48

    PubMed  Google Scholar 

  3. Green OC, Winter RJ, Kawahara FS, Phillips LS, Lewy PR, Hart RL, Pachman LM (1978) Pharmacokinetic studies of prednisolone in children. J Pediatr 93: 299–303

    PubMed  Google Scholar 

  4. Rocci ML, Assael BM, Appiani AC, Edefonti A, Jusko WJ (1982) Effect of nephrotic syndrome on absorption and disposition of prednisolone in children. Int J Pediatr Nephrol 3: 161–166

    Google Scholar 

  5. Kleinknecht C, Gubler MC, Néphrose (1983) In: Royer P, Habib R, Mathieu H, Broyer M (eds) Néphrologie pédiatrique, 3rd edn Flammarion, Paris, pp 274–293

    Google Scholar 

  6. Alvinerie M, Toutain PL (1982) Simultaneous determination of corticosterone, hydrocortisone and dexamethasone in dog plasma using high performance liquid chromatography. J Pharm Sci 71: 816–818

    PubMed  Google Scholar 

  7. Pickup ME (1979) Clinical pharmacokinetics of prednisone and prednisolone. Clin Pharmacokinet 4: 111–128

    PubMed  Google Scholar 

  8. Rose JQ, Yurchak AM, Jusko WJ (1981) Dose-dependent pharmacokinetics of prednisone and prednisolone in man. J Pharmacokinet Biopharm 9: 389–417

    PubMed  Google Scholar 

  9. Baron S, Raux Demay MC, Vasman D, Bensman A (1988) Pharmacocinetique de la prednisolone chez l'enfant. Presse Med 17: 632–635

    PubMed  Google Scholar 

  10. Demotes-Mainard F, Potaux L, Aparicio M, De Precigout V, Vinçon G, Albin H (1986) Pharmacocinétique de la prednisolone chez des malades transplantés rénaux avec ou sans syndrome de Cushing. Therapie 41: 449–454

    PubMed  Google Scholar 

  11. Gambertoglio JG, Amend WJC, Benet LZ (1980) Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients. a review. J Pharmacokinet Biopharm 8: 1–52

    PubMed  Google Scholar 

  12. Jusko WJ, Rose JQ (1980) Monitoring prednisone and prednisolone. Ther Drug Monit 2: 169–176

    PubMed  Google Scholar 

  13. Gambertoglio JG, Frey FJ, Holford NHG, Birnbaum JL, Stanik Lizak P, Vincenti F, Feduska NJ, Salvatierra O, Amend WJC (1982) Prednisone and prednisolone bioavailability in renal transplant patients. Kidney Int 21: 621–626

    PubMed  Google Scholar 

  14. Habet S, Rogers HJ (1980) Pharmacokinetics of intravenous and oral prednisolone. Br J Clin Pharmacol 10: 503–508

    PubMed  Google Scholar 

  15. Perignon F, Pecquinot MA, Ged C, Antignac C, Guest G, Tete MJ, Broyer M, Lenoir G (1985) Pharmacocinétique de la prednisone après dose orale chez l'enfant greffé rénal. Arch Fr Pediatr 42: 639–644

    PubMed  Google Scholar 

  16. Frey FJ, Amend WJC, Lozada JF, Frey BM, Benet LZ (1981) Endogenous hydrocortisone, a possible factor contributing to the genesis of cushingoid habitus in patients on prednisone. J Clin Endocrinal Metab 53: 1076–1080

    Google Scholar 

  17. Murnaghan K, Vasmant D, Bensman A (1984) Pulse methyl prednisolone therapy in severe idiopathic childhood nephrotic syndrome. Acta Paediatr Scand 73: 733–739

    PubMed  Google Scholar 

  18. Lewis GP, Jusko WJ, Burke CW, Graves L (1971) Prednisone side effects and serum-protein levels. Lancet II: 778–781

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rostin, M., Barthe, P., Houin, G. et al. Pharmacokinetics of prednisolone in children with the nephrotic syndrome. Pediatr Nephrol 4, 470–473 (1990). https://doi.org/10.1007/BF00869822

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00869822

Key words

Navigation